28 Results for "

51042

" in MedChemExpress (MCE) Product Catalog:
Products (28)

28 Results for "51042" in MCE Product Catalog:

6
6 Cited Publications
Cat. No.: HY-B0793
CAS No.: 1421373-98-9
Target:  

EGFR

Research Areas:  

Cancer

AZ-5104 is an active, demethylated metabolite of AZD 9291. AZ-5104 is an EGFR inhibitor with IC50s of 1, 6, 1, 25 and 7 nM for EGFR L858R/T790M, EGFR L858R, EGFR L861Q, EGFR and ErbB4, respectively.
Cat. No.: HY-P99572
CAS No.: 2253891-70-0
Synonyms: BNT-312; DuoBody-CD40x-4-1BB; GEN1042

Target:  

TNF Receptor

Research Areas:  

Inflammation/Immunology Cancer

Tecaginlimab (BNT-312) is a Fc-inert bispecific antibody for dual targeting and conditional stimulation of CD40 and 4-1BB. Tecaginlimab can enhance priming and reactivation of tumor-specific immunity .
Cat. No.: HY-P99835
CAS No.: 1095207-05-8
Synonyms: MABT 5102A; RG 7412

Target:  

Amyloid-β

Research Areas:  

Neurological Disease

Crenezumab (MABT 5102A; RG 7412) is a fully humanized anti-Aβ monoclonal antibody that binds multiple forms of Aβ, such as soluble, oligomeric and fibrillar, for use in Alzheimer's disease research .
Cat. No.: HY-125331
CAS No.: 200619-13-2
Purity:  98.05%
Research Areas:  

Cancer

DRF-1042 is an orally active derivative of Camptothecin. DRF-1042 acts to inhibit DNA topoisomerase I. DRF-1042 shows good anticancer activity against a panel of human cancer cell lines including multi-agent resistance (MDR) phenotype .
Cat. No.: HY-U00094
CAS No.: 14782-19-5
Target:  

Drug Derivative

Research Areas:  

Inflammation/Immunology

INO5042, a thiazole fused 1,4-naphthoquinone compound, and exhibits anti-inflammation activity .
Cat. No.: HY-W517264
CAS No.: 51997-43-4
Synonyms: BM 51052 hydrochloride
Target:  

Adrenergic Receptor

Research Areas:  

Cardiovascular Disease

Carazolol (BM 51052) hydrochloride is a highly potent antagonist of β12 adrenoceptor. Carazolol hydrochloride is also a potent, selective β3-adrenoceptor agonist. Carazolol hydrochloride can be used in the research of hypertension .
Cat. No.: HY-136634
CAS No.: 72293-40-4
Target:  

mAChR

Research Areas:  

Others

BTM-1042 is a newly synthesized compound with antispasmodic effects. It can inhibit the twitch reaction of the guinea pig ileum under electrical stimulation and is not affected by naloxone. It has similar effects to atropine and can block muscarinic receptors, but has less effect on other types of receptors. BTM-1042 also has an inhibitory effect on the ileal reaction caused by nicotine and 5-hydroxytryptamine. BTM-1042 showed a dose-dependent inhibitory effect on the spontaneous movement of the rabbit stomach. In general, BTM-1042 is a agent with a strong antispasmodic effect.
Cat. No.: HY-P990268

Target:  

Phosphatase

Research Areas:  

Inflammation/Immunology

Anti-Mouse CD45.2 Antibody (104.2) is a mouse-derived IgG2a κ type antibody inhibitor, targeting to mouse CD45.2. Anti-Mouse CD45.2 Antibody (104.2) can inhibit B Cell differentiation. Anti-Mouse CD45.2 Antibody (104.2) can be used for the researches of inflammation and immunology, such as LPS (HY-D1056)-induced inflammation and autoimmunity .
Cat. No.: HY-I0903
CAS No.: 161532-65-6
Target:  

Fungal

Research Areas:  

Others

SCH 51048 is a compound that can produce active metabolites, and its active metabolites have antifungal activity. Through metabolic studies and activity screening of the compound, metabolites and compounds with better activity were discovered.
Cat. No.: HY-B0793S1
CAS No.: 2719691-01-5
AZ-5104-d2 is the deuterium labeled AZ-5104. AZ-5104 is an EGFR inhibitor with IC50s of 1 nM, 6 nM, 1 nM, 25 nM and 7 nM for EGFRL858R/T790M, EGFRL858R, EGFRL861Q, EGFR and ErbB4, respectively .
Cat. No.: HY-R03249
Target:  

MicroRNA

Research Areas:  

Cancer

mmu-miR-5104 mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
Cat. No.: HY-W324493
CAS No.: 35853-50-0
Synonyms: Ro 21-5104
Target:  

Drug Metabolite

Research Areas:  

Infection

Carboxymefloquine is a metabolite of Mefloquine (HY-17437) (an antimalarial agent). Carboxymefloquine can be used in malaria research .
Cat. No.: HY-R03250
Target:  

MicroRNA

Research Areas:  

Cancer

mmu-miR-5104b-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
Cat. No.: HY-RI03250A
Target:  

MicroRNA

Research Areas:  

Cancer

mmu-miR-5104b-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
Cat. No.: HY-124908
CAS No.: 23589-77-7
Target:  

Drug Derivative

Research Areas:  

Others

HT1042 is an active compound.
Cat. No.: HY-180355
CAS No.: 2365230-48-2
Research Areas:  

Cancer

SY-5102 is a potent, selective and orally active cyclin-dependent kinase (CDK7) inhibitor with a Kd of 0.03 nM. SY-5102 shows anti-proliferative activity against HCC70 cells with an EC50 of 9 nM. SY-5102 can inhibit CDK7-mediated CAK function (downregulate CDK2 Thr160 phosphorylation) and TFIIH transcription function (downregulate RNA polymerase II Ser5 phosphorylation). SY-5102 can induce G2/M cell cycle arrest, downregulate the expression of the oncogene c-Myc, and ultimately trigger cancer cell apoptosis. SY-5102 can be used for the research of triple-negative breast cancer (TNBC) .
Cat. No.: HY-W879508
CAS No.: 173026-17-0
Synonyms: BXT-51072
ALT-2074 (BXT-51071) is an orally active catalytic analogue of glutathione peroxidase. ALT-2074 is an inhibitor of human CYP3A, with its IC50 value ranging from 2.0 to 2.6 μM. ALT-2074 shows only a weak inhibitory effect on CYP3A in vivo, suggesting that it may not significantly affect the metabolism of CYP3A substrate drugs. ALT-2074 can be used to study inflammatory diseases characterized by reactive oxygen species, such as acute coronary syndrome .
Cat. No.: HY-R03249A
Target:  

MicroRNA

Research Areas:  

Cancer

mmu-miR-5104 agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
Cat. No.: HY-RI03249
Target:  

MicroRNA

Research Areas:  

Cancer

mmu-miR-5104 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
Cat. No.: HY-RI03249A
Target:  

MicroRNA

Research Areas:  

Cancer

mmu-miR-5104 antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.